Literature DB >> 23907729

Protein sumoylation in brain development, neuronal morphology and spinogenesis.

Carole Gwizdek1, Frédéric Cassé, Stéphane Martin.   

Abstract

Small ubiquitin-like modifiers (SUMOs) are polypeptides resembling ubiquitin that are covalently attached to specific lysine residue of target proteins through a specific enzymatic pathway. Sumoylation is now seen as a key posttranslational modification involved in many biological processes, but little is known about how this highly dynamic protein modification is regulated in the brain. Disruption of the sumoylation enzymatic pathway during the embryonic development leads to lethality revealing a pivotal role for this protein modification during development. The main aim of this review is to briefly describe the SUMO pathway and give an overview of the sumoylation regulations occurring in brain development, neuronal morphology and synapse formation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23907729     DOI: 10.1007/s12017-013-8252-z

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   3.843


  120 in total

Review 1.  Molecular control of cortical dendrite development.

Authors:  Kristin L Whitford; Paul Dijkhuizen; Franck Polleux; Anirvan Ghosh
Journal:  Annu Rev Neurosci       Date:  2002-03-19       Impact factor: 12.449

2.  Insights into high affinity small ubiquitin-like modifier (SUMO) recognition by SUMO-interacting motifs (SIMs) revealed by a combination of NMR and peptide array analysis.

Authors:  Andrew T Namanja; Yi-Jia Li; Yang Su; Steven Wong; Jingjun Lu; Loren T Colson; Chenggang Wu; Shawn S C Li; Yuan Chen
Journal:  J Biol Chem       Date:  2011-12-06       Impact factor: 5.157

3.  TRAF7 sequesters c-Myb to the cytoplasm by stimulating its sumoylation.

Authors:  Yutaka Morita; Chie Kanei-Ishii; Teruaki Nomura; Shunsuke Ishii
Journal:  Mol Biol Cell       Date:  2005-09-14       Impact factor: 4.138

4.  Defective sumoylation pathway directs congenital heart disease.

Authors:  Jun Wang; Li Chen; Shu Wen; Huiping Zhu; Wei Yu; Ivan P Moskowitz; Gary M Shaw; Richard H Finnell; Robert J Schwartz
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2011-05-11

5.  The nucleoporin RanBP2 has SUMO1 E3 ligase activity.

Authors:  Andrea Pichler; Andreas Gast; Jacob S Seeler; Anne Dejean; Frauke Melchior
Journal:  Cell       Date:  2002-01-11       Impact factor: 41.582

6.  Topors acts as a SUMO-1 E3 ligase for p53 in vitro and in vivo.

Authors:  Stefan Weger; Eva Hammer; Regine Heilbronn
Journal:  FEBS Lett       Date:  2005-09-12       Impact factor: 4.124

Review 7.  Sumoylation in neurodegenerative diseases.

Authors:  Petranka Krumova; Jochen H Weishaupt
Journal:  Cell Mol Life Sci       Date:  2012-09-25       Impact factor: 9.261

8.  Analysis of SUMO-1 modification of neuronal proteins containing consensus SUMOylation motifs.

Authors:  Kevin A Wilkinson; Atsushi Nishimune; Jeremy M Henley
Journal:  Neurosci Lett       Date:  2008-03-15       Impact factor: 3.046

Review 9.  Emerging extranuclear roles of protein SUMOylation in neuronal function and dysfunction.

Authors:  Stéphane Martin; Kevin A Wilkinson; Atsushi Nishimune; Jeremy M Henley
Journal:  Nat Rev Neurosci       Date:  2007-12       Impact factor: 34.870

10.  Phosphorylation-facilitated sumoylation of MEF2C negatively regulates its transcriptional activity.

Authors:  Jungseog Kang; Christian B Gocke; Hongtao Yu
Journal:  BMC Biochem       Date:  2006-02-14       Impact factor: 4.059

View more
  14 in total

1.  SUMOylation in neuroplasticity and neurological disorders.

Authors:  Marco Feligioni; Mark P Mattson; Robert Nisticò
Journal:  Neuromolecular Med       Date:  2013-12       Impact factor: 3.843

Review 2.  Post-translational modifications of the Fragile X Mental Retardation Protein in neuronal function and dysfunction.

Authors:  Marta Prieto; Alessandra Folci; Stéphane Martin
Journal:  Mol Psychiatry       Date:  2019-12-10       Impact factor: 15.992

3.  19q13.11 microdeletion concomitant with ins(2;19)(p25.3;q13.1q13.4)dn in a boy: potential role of UBA2 in the associated phenotype.

Authors:  Carlos Venegas-Vega; Karem Nieto-Martínez; Alejandro Martínez-Herrera; Laura Gómez-Laguna; Jaime Berumen; Alicia Cervantes; Susana Kofman; Fernando Fernández-Ramírez
Journal:  Mol Cytogenet       Date:  2014-12-12       Impact factor: 2.009

Review 4.  Sumoylation in Synaptic Function and Dysfunction.

Authors:  Lenka Schorova; Stéphane Martin
Journal:  Front Synaptic Neurosci       Date:  2016-04-28

5.  The language-related transcription factor FOXP2 is post-translationally modified with small ubiquitin-like modifiers.

Authors:  Sara B Estruch; Sarah A Graham; Pelagia Deriziotis; Simon E Fisher
Journal:  Sci Rep       Date:  2016-02-12       Impact factor: 4.379

6.  Analysis of SUMO1-conjugation at synapses.

Authors:  James A Daniel; Benjamin H Cooper; Jorma J Palvimo; Fu-Ping Zhang; Nils Brose; Marilyn Tirard
Journal:  Elife       Date:  2017-06-09       Impact factor: 8.140

7.  Comprehensive whole genome sequence analyses yields novel genetic and structural insights for Intellectual Disability.

Authors:  Farah R Zahir; Jill C Mwenifumbo; Hye-Jung E Chun; Emilia L Lim; Clara D M Van Karnebeek; Madeline Couse; Karen L Mungall; Leora Lee; Nancy Makela; Linlea Armstrong; Cornelius F Boerkoel; Sylvie L Langlois; Barbara M McGillivray; Steven J M Jones; Jan M Friedman; Marco A Marra
Journal:  BMC Genomics       Date:  2017-05-24       Impact factor: 3.969

8.  PDPK1 regulates autophagosome biogenesis by binding to PIK3C3.

Authors:  Boli Hu; Yina Zhang; Tingjuan Deng; Jinyan Gu; Juan Liu; Hui Yang; Yuting Xu; Yan Yan; Fan Yang; Heng Zhang; Yulan Jin; Jiyong Zhou
Journal:  Autophagy       Date:  2020-09-10       Impact factor: 16.016

9.  Tracking the activity-dependent diffusion of synaptic proteins using restricted photoconversion of Dendra2.

Authors:  Frédéric Cassé; Stéphane Martin
Journal:  Front Cell Neurosci       Date:  2015-09-22       Impact factor: 5.505

10.  SETX sumoylation: A link between DNA damage and RNA surveillance disrupted in AOA2.

Authors:  Patricia Richard; James L Manley
Journal:  Rare Dis       Date:  2014-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.